Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Tax Provisions (2018 - 2025)

AVITA Medical filings provide 8 years of Tax Provisions readings, the most recent being -$17000.0 for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 189.47% to -$17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $10000.0, a 81.48% decrease, with the full-year FY2025 number at $11000.0, down 79.63% from a year prior.
  • Tax Provisions hit -$17000.0 in Q4 2025 for AVITA Medical, down from $15000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $33000.0 in Q2 2024 to a low of -$28000.0 in Q3 2024.
  • Median Tax Provisions over the past 5 years was $10500.0 (2021), compared with a mean of $10277.8.
  • Biggest five-year swings in Tax Provisions: soared 650.0% in 2023 and later tumbled 354.55% in 2024.
  • AVITA Medical's Tax Provisions stood at $6000.0 in 2021, then soared by 300.0% to $24000.0 in 2022, then crashed by 50.0% to $12000.0 in 2023, then surged by 58.33% to $19000.0 in 2024, then tumbled by 189.47% to -$17000.0 in 2025.
  • The last three reported values for Tax Provisions were -$17000.0 (Q4 2025), $15000.0 (Q3 2025), and $4000.0 (Q2 2025) per Business Quant data.